Related Experiment Videos

c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation

N Ben-Baruch1, W C Reinhold, N Alexandrova

  • 1Laboratory of Biological Chemistry, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Insights

Suramin rapidly reduces c-myc expression and inhibits HL60 cell growth. However, this c-myc down-regulation does not induce hematopoietic cell differentiation, indicating it

Area of Science:

  • Hematopoietic cell biology
  • Cancer research
  • Molecular oncology

Background:

  • c-myc mRNA expression is crucial for hematopoietic cell growth and differentiation.
  • Understanding c-myc regulation is key to controlling cell proliferation and lineage commitment.

Purpose of the Study:

  • To investigate the effect of suramin on c-myc expression in HL60 cells.
  • To determine if suramin-induced c-myc down-regulation triggers hematopoietic cell differentiation.

Main Methods:

  • Treatment of HL60 cells with suramin.
  • Quantification of c-myc mRNA and protein levels over time.
  • Assessment of cell differentiation markers.

Main Results:

  • Suramin treatment led to a rapid decrease in both c-myc mRNA and protein levels in HL60 cells.
  • Cell growth was inhibited following suramin exposure.
  • Unlike known differentiation agents, suramin did not induce granulocytic or monocytic differentiation.

Conclusions:

  • Suramin effectively modulates c-myc expression in HL60 cells.
  • Down-regulation of c-myc alone is insufficient to induce differentiation in these cells.
  • Suramin's mechanism does not involve triggering differentiation pathways despite c-myc modulation.

Related Concept Videos